EQUINOX GOLD CORP (EQX)

CA29446Y5020 - Common Stock

5.98  +0.15 (+2.57%)

Premarket: 6.0117 +0.03 (+0.53%)

Fundamental Rating

4

EQX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 154 industry peers in the Metals & Mining industry. EQX has a medium profitability rating, but doesn't score so well on its financial health evaluation. EQX is not overvalued while it is showing excellent growth. This is an interesting combination.



5

1. Profitability

1.1 Basic Checks

In the past year EQX was profitable.
EQX had a positive operating cash flow in the past year.
In multiple years EQX reported negative net income over the last 5 years.
EQX had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

EQX's Return On Assets of 3.59% is fine compared to the rest of the industry. EQX outperforms 71.43% of its industry peers.
The Return On Equity of EQX (7.55%) is better than 72.11% of its industry peers.
EQX has a Return On Invested Capital of 1.53%. This is comparable to the rest of the industry: EQX outperforms 46.26% of its industry peers.
EQX had an Average Return On Invested Capital over the past 3 years of 1.62%. This is significantly below the industry average of 8.76%.
Industry RankSector Rank
ROA 3.59%
ROE 7.55%
ROIC 1.53%
ROA(3y)3.97%
ROA(5y)2.11%
ROE(3y)6.05%
ROE(5y)3.02%
ROIC(3y)1.62%
ROIC(5y)3.47%

1.3 Margins

EQX has a Profit Margin of 19.82%. This is amongst the best in the industry. EQX outperforms 89.80% of its industry peers.
EQX's Profit Margin has been stable in the last couple of years.
EQX has a better Operating Margin (9.34%) than 63.27% of its industry peers.
EQX's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 31.36%, EQX is in the better half of the industry, outperforming 72.79% of the companies in the same industry.
EQX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.34%
PM (TTM) 19.82%
GM 31.36%
OM growth 3Y-41.94%
OM growth 5YN/A
PM growth 3Y0.23%
PM growth 5YN/A
GM growth 3Y-15.83%
GM growth 5Y-4.21%

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EQX is destroying value.
The number of shares outstanding for EQX has been increased compared to 1 year ago.
EQX has more shares outstanding than it did 5 years ago.
EQX has a better debt/assets ratio than last year.

2.2 Solvency

EQX has an Altman-Z score of 0.79. This is a bad value and indicates that EQX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.79, EQX is not doing good in the industry: 77.55% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.37 indicates that EQX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.37, EQX is doing worse than 70.07% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z 0.79
ROIC/WACC0.15
WACC10.31%

2.3 Liquidity

EQX has a Current Ratio of 0.85. This is a bad value and indicates that EQX is not financially healthy enough and could expect problems in meeting its short term obligations.
EQX has a worse Current ratio (0.85) than 88.44% of its industry peers.
A Quick Ratio of 0.33 indicates that EQX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.33, EQX is doing worse than 94.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.33

8

3. Growth

3.1 Past

EQX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 226.52%, which is quite impressive.
Measured over the past years, EQX shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.64% on average per year.
EQX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.84%.
The Revenue has been growing by 104.86% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)226.52%
EPS 3Y-3.64%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)17.84%
Revenue growth 3Y8.78%
Revenue growth 5Y104.86%
Sales Q2Q%50.45%

3.2 Future

EQX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 316.41% yearly.
Based on estimates for the next years, EQX will show a quite strong growth in Revenue. The Revenue will grow by 19.37% on average per year.
EPS Next Y32211.2%
EPS Next 2Y2824.98%
EPS Next 3Y925.04%
EPS Next 5Y316.41%
Revenue Next Year42.96%
Revenue Next 2Y50.15%
Revenue Next 3Y33.06%
Revenue Next 5Y19.37%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 119.60, which means the current valuation is very expensive for EQX.
The rest of the industry has a similar Price/Earnings ratio as EQX.
EQX is valuated expensively when we compare the Price/Earnings ratio to 27.28, which is the current average of the S&P500 Index.
EQX is valuated cheaply with a Price/Forward Earnings ratio of 5.54.
EQX's Price/Forward Earnings ratio is rather cheap when compared to the industry. EQX is cheaper than 92.52% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.53. EQX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 119.6
Fwd PE 5.54

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as EQX.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.31

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EQX's earnings are expected to grow with 925.03% in the coming years.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y2824.98%
EPS Next 3Y925.04%

0

5. Dividend

5.1 Amount

EQX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EQUINOX GOLD CORP

NYSEARCA:EQX (1/14/2025, 8:04:00 PM)

Premarket: 6.0117 +0.03 (+0.53%)

5.98

+0.15 (+2.57%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-19 2025-02-19/amc
Inst Owners53.69%
Inst Owner Change0%
Ins Owners5.77%
Ins Owner ChangeN/A
Market Cap2.72B
Analysts80
Price Target10.71 (79.1%)
Short Float %4.39%
Short Ratio3.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.86%
Min EPS beat(2)-24.27%
Max EPS beat(2)33.99%
EPS beat(4)3
Avg EPS beat(4)48.52%
Min EPS beat(4)-24.27%
Max EPS beat(4)139.6%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.02%
Min Revenue beat(2)-12.93%
Max Revenue beat(2)-3.12%
Revenue beat(4)0
Avg Revenue beat(4)-9.28%
Min Revenue beat(4)-13.9%
Max Revenue beat(4)-3.12%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.46%
EPS NY rev (1m)0%
EPS NY rev (3m)10.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.03%
Revenue NY rev (1m)-0.75%
Revenue NY rev (3m)-0.44%
Valuation
Industry RankSector Rank
PE 119.6
Fwd PE 5.54
P/S 2.2
P/FCF N/A
P/OCF 10.88
P/B 0.84
P/tB 0.84
EV/EBITDA 12.31
EPS(TTM)0.05
EY0.84%
EPS(NY)1.08
Fwd EY18.06%
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)0.55
OCFY9.19%
SpS2.72
BVpS7.13
TBVpS7.13
PEG (NY)0
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.59%
ROE 7.55%
ROCE 1.93%
ROIC 1.53%
ROICexc 1.57%
ROICexgc 1.57%
OM 9.34%
PM (TTM) 19.82%
GM 31.36%
FCFM N/A
ROA(3y)3.97%
ROA(5y)2.11%
ROE(3y)6.05%
ROE(5y)3.02%
ROIC(3y)1.62%
ROIC(5y)3.47%
ROICexc(3y)1.87%
ROICexc(5y)3.96%
ROICexgc(3y)1.87%
ROICexgc(5y)3.96%
ROCE(3y)2.05%
ROCE(5y)4.4%
ROICexcg growth 3Y-47.11%
ROICexcg growth 5YN/A
ROICexc growth 3Y-47.11%
ROICexc growth 5YN/A
OM growth 3Y-41.94%
OM growth 5YN/A
PM growth 3Y0.23%
PM growth 5YN/A
GM growth 3Y-15.83%
GM growth 5Y-4.21%
F-Score6
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA 3.7
Cap/Depr 215.04%
Cap/Sales 36.75%
Interest Coverage 1.26
Cash Conversion 76.54%
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.33
Altman-Z 0.79
F-Score6
WACC10.31%
ROIC/WACC0.15
Cap/Depr(3y)236.96%
Cap/Depr(5y)215.01%
Cap/Sales(3y)46.13%
Cap/Sales(5y)38.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)226.52%
EPS 3Y-3.64%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y32211.2%
EPS Next 2Y2824.98%
EPS Next 3Y925.04%
EPS Next 5Y316.41%
Revenue 1Y (TTM)17.84%
Revenue growth 3Y8.78%
Revenue growth 5Y104.86%
Sales Q2Q%50.45%
Revenue Next Year42.96%
Revenue Next 2Y50.15%
Revenue Next 3Y33.06%
Revenue Next 5Y19.37%
EBIT growth 1Y207.41%
EBIT growth 3Y-36.84%
EBIT growth 5YN/A
EBIT Next Year1197.1%
EBIT Next 3Y209.11%
EBIT Next 5Y102.13%
FCF growth 1Y43.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.44%
OCF growth 3Y11.91%
OCF growth 5YN/A